Northeast Pharmaceutical Group Management
Management criteria checks 2/4
Northeast Pharmaceutical Group's CEO is Zhou Kai, appointed in May 2019, has a tenure of 5.67 years. directly owns 0.3% of the company’s shares, worth CN¥21.06M. The average tenure of the management team and the board of directors is 1.1 years and 5.2 years respectively.
Key information
Zhou Kai
Chief executive officer
CN¥1.8m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 5.7yrs |
| CEO ownership | 0.3% |
| Management average tenure | 1.1yrs |
| Board average tenure | 5.2yrs |
Recent management updates
Recent updates
We Think Northeast Pharmaceutical Group (SZSE:000597) Can Manage Its Debt With Ease
Dec 02
Northeast Pharmaceutical Group Co., Ltd. (SZSE:000597) Soars 27% But It's A Story Of Risk Vs Reward
Nov 08Northeast Pharmaceutical Group's (SZSE:000597) Weak Earnings May Only Reveal A Part Of The Whole Picture
Oct 30It's A Story Of Risk Vs Reward With Northeast Pharmaceutical Group Co., Ltd. (SZSE:000597)
Aug 07These 4 Measures Indicate That Northeast Pharmaceutical Group (SZSE:000597) Is Using Debt Safely
May 25Northeast Pharmaceutical Group (SZSE:000597) Is Posting Promising Earnings But The Good News Doesn’t Stop There
Apr 05CEO
Zhou Kai (60 yo)
5.7yrs
Tenure
CN¥1,824,100
Compensation
Mr. Zhou Kai serves as a General Manager of Northeast Pharmaceutical Group Co., Ltd. since May 8, 2019 and serves its Non-Independent Director since November 29, 2020. He served as a Vice President of Nort...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Director | 5.7yrs | CN¥1.82m | 0.30% CN¥ 21.1m | |
| Deputy General Manager | 1.1yrs | CN¥894.30k | no data | |
| Deputy General Manager | 1yr | no data | no data |
1.1yrs
Average Tenure
59yo
Average Age
Experienced Management: 000597's management team is not considered experienced ( 1.1 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Director | 4.2yrs | CN¥1.82m | 0.30% CN¥ 21.1m | |
| Independent Director | 6.5yrs | CN¥150.00k | no data | |
| Non-Independent Director | 3.2yrs | no data | no data | |
| Non-Independent Director | 6.5yrs | no data | 0.23% CN¥ 16.1m | |
| Non-Independent Director | 6.5yrs | no data | 0.23% CN¥ 16.1m | |
| Independent Director | 6.5yrs | CN¥150.00k | no data | |
| Independent Director | 6.5yrs | CN¥150.00k | no data | |
| Independent Director | 4.3yrs | CN¥150.00k | no data | |
| Chairman of the Board | 3.3yrs | CN¥2.07m | 0.22% CN¥ 15.9m | |
| Non-Independent Director | 3.2yrs | no data | 0.070% CN¥ 5.0m | |
| Chairman of the Supervisory Board | 6.1yrs | no data | no data | |
| Director | 1.3yrs | no data | no data |
5.2yrs
Average Tenure
59yo
Average Age
Experienced Board: 000597's board of directors are considered experienced (5.2 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/28 23:29 |
| End of Day Share Price | 2025/01/27 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Northeast Pharmaceutical Group Co., Ltd. is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jie Yao | Citic Securities Co., Ltd. |
| Xiaoming Liu | Guoyuan Securities Co., Ltd. |
| Yining Zheng | Topsperity Securities |